Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immune Reconstitution Inflammatory Syndrome | 3 | 2017 | 17 | 1.080 |
Why?
|
| Radiography, Thoracic | 1 | 2026 | 117 | 0.900 |
Why?
|
| Measles | 2 | 2016 | 3 | 0.880 |
Why?
|
| Abscess | 3 | 2018 | 78 | 0.860 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2017 | 31 | 0.860 |
Why?
|
| Travel | 2 | 2016 | 44 | 0.850 |
Why?
|
| Bacteremia | 3 | 2017 | 91 | 0.840 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2026 | 1656 | 0.770 |
Why?
|
| Pneumonia | 1 | 2026 | 291 | 0.760 |
Why?
|
| Antitubercular Agents | 2 | 2019 | 82 | 0.690 |
Why?
|
| Immunocompromised Host | 2 | 2012 | 103 | 0.680 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2012 | 86 | 0.680 |
Why?
|
| HIV Infections | 4 | 2017 | 955 | 0.660 |
Why?
|
| Antiviral Agents | 2 | 2014 | 321 | 0.640 |
Why?
|
| Influenza, Human | 2 | 2012 | 203 | 0.600 |
Why?
|
| Emigration and Immigration | 1 | 2019 | 28 | 0.590 |
Why?
|
| Latent Tuberculosis | 1 | 2019 | 24 | 0.580 |
Why?
|
| Cellulitis | 1 | 2018 | 16 | 0.550 |
Why?
|
| Medication Adherence | 1 | 2019 | 199 | 0.540 |
Why?
|
| Obesity | 1 | 2026 | 1273 | 0.530 |
Why?
|
| Enterococcus faecalis | 1 | 2017 | 12 | 0.510 |
Why?
|
| Rhizopus | 1 | 2016 | 5 | 0.510 |
Why?
|
| Aspergillus | 1 | 2016 | 10 | 0.500 |
Why?
|
| Mucormycosis | 1 | 2016 | 9 | 0.500 |
Why?
|
| Anti-Bacterial Agents | 7 | 2026 | 801 | 0.500 |
Why?
|
| Lung Diseases, Fungal | 1 | 2016 | 34 | 0.500 |
Why?
|
| Aspergillosis | 1 | 2016 | 35 | 0.500 |
Why?
|
| Disease Outbreaks | 2 | 2016 | 110 | 0.500 |
Why?
|
| Gonorrhea | 1 | 2018 | 162 | 0.470 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2018 | 204 | 0.470 |
Why?
|
| Tuberculosis | 2 | 2017 | 306 | 0.460 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 130 | 0.450 |
Why?
|
| Health Personnel | 1 | 2019 | 385 | 0.440 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 220 | 0.440 |
Why?
|
| Bifidobacteriales Infections | 1 | 2014 | 1 | 0.440 |
Why?
|
| Bifidobacterium | 1 | 2014 | 16 | 0.430 |
Why?
|
| Encephalitis, Varicella Zoster | 1 | 2014 | 2 | 0.420 |
Why?
|
| Acyclovir | 1 | 2014 | 20 | 0.420 |
Why?
|
| Hallucinations | 1 | 2014 | 17 | 0.420 |
Why?
|
| Speech Disorders | 1 | 2014 | 18 | 0.420 |
Why?
|
| Diarrhea | 1 | 2014 | 73 | 0.420 |
Why?
|
| Homosexuality, Male | 1 | 2014 | 29 | 0.420 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2013 | 2 | 0.410 |
Why?
|
| Clostridium Infections | 1 | 2014 | 49 | 0.410 |
Why?
|
| Religion | 1 | 2014 | 35 | 0.410 |
Why?
|
| Travel Medicine | 1 | 2013 | 3 | 0.400 |
Why?
|
| Whooping Cough | 1 | 2013 | 10 | 0.400 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 366 | 0.400 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 97 | 0.400 |
Why?
|
| Prostatic Diseases | 1 | 2013 | 9 | 0.390 |
Why?
|
| Humans | 25 | 2026 | 65109 | 0.380 |
Why?
|
| Subcutaneous Tissue | 1 | 2012 | 15 | 0.380 |
Why?
|
| Drug Eruptions | 1 | 2012 | 17 | 0.380 |
Why?
|
| Anti-HIV Agents | 2 | 2017 | 139 | 0.380 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2012 | 7 | 0.380 |
Why?
|
| Enterococcus | 1 | 2012 | 10 | 0.370 |
Why?
|
| Liver Failure | 1 | 2012 | 18 | 0.370 |
Why?
|
| Virus Shedding | 1 | 2012 | 17 | 0.370 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 66 | 0.370 |
Why?
|
| Oseltamivir | 1 | 2012 | 35 | 0.360 |
Why?
|
| Naltrexone | 1 | 2012 | 91 | 0.360 |
Why?
|
| Endocarditis, Bacterial | 1 | 2012 | 36 | 0.360 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2012 | 14 | 0.360 |
Why?
|
| Pneumonia, Bacterial | 1 | 2012 | 90 | 0.350 |
Why?
|
| Narcotic Antagonists | 1 | 2012 | 133 | 0.340 |
Why?
|
| Aortic Valve | 1 | 2012 | 181 | 0.320 |
Why?
|
| Cryptococcus neoformans | 1 | 2012 | 142 | 0.320 |
Why?
|
| Male | 13 | 2026 | 31025 | 0.320 |
Why?
|
| Genital Neoplasms, Male | 1 | 2009 | 1 | 0.300 |
Why?
|
| Skin | 1 | 2012 | 422 | 0.300 |
Why?
|
| Middle Aged | 9 | 2026 | 18262 | 0.300 |
Why?
|
| Genital Neoplasms, Female | 1 | 2009 | 18 | 0.300 |
Why?
|
| Alphapapillomavirus | 1 | 2009 | 19 | 0.290 |
Why?
|
| Listeriosis | 1 | 2008 | 29 | 0.280 |
Why?
|
| Leprosy | 1 | 2008 | 8 | 0.280 |
Why?
|
| Female | 11 | 2026 | 34008 | 0.270 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2008 | 67 | 0.270 |
Why?
|
| Pericarditis | 1 | 2007 | 10 | 0.270 |
Why?
|
| Pericardial Effusion | 1 | 2007 | 22 | 0.270 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 133 | 0.260 |
Why?
|
| Heart Transplantation | 1 | 2008 | 180 | 0.250 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 704 | 0.230 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 991 | 0.230 |
Why?
|
| Fatal Outcome | 2 | 2016 | 122 | 0.210 |
Why?
|
| Retrospective Studies | 3 | 2026 | 6860 | 0.210 |
Why?
|
| Sensitivity and Specificity | 1 | 2026 | 1163 | 0.190 |
Why?
|
| Aged | 5 | 2026 | 14952 | 0.190 |
Why?
|
| Vaccination | 2 | 2016 | 375 | 0.180 |
Why?
|
| Adult | 5 | 2019 | 17353 | 0.170 |
Why?
|
| Osteoradionecrosis | 1 | 2019 | 4 | 0.150 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2019 | 17 | 0.150 |
Why?
|
| Symptom Assessment | 1 | 2018 | 48 | 0.130 |
Why?
|
| Spinal Fusion | 1 | 2019 | 156 | 0.130 |
Why?
|
| Soil Microbiology | 1 | 2016 | 11 | 0.130 |
Why?
|
| Measles Vaccine | 1 | 2016 | 2 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 5607 | 0.110 |
Why?
|
| Biopsy | 1 | 2016 | 456 | 0.110 |
Why?
|
| Metronidazole | 1 | 2014 | 10 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 2014 | 9 | 0.110 |
Why?
|
| Hospitals, Community | 1 | 2014 | 71 | 0.100 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 29 | 0.100 |
Why?
|
| Phenotype | 1 | 2018 | 1231 | 0.100 |
Why?
|
| Aneurysm, Infected | 1 | 2013 | 13 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2014 | 576 | 0.100 |
Why?
|
| Massachusetts | 1 | 2019 | 2144 | 0.100 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 25 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5784 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2014 | 93 | 0.100 |
Why?
|
| Injections, Intramuscular | 1 | 2012 | 71 | 0.090 |
Why?
|
| Debridement | 1 | 2012 | 35 | 0.090 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2013 | 108 | 0.090 |
Why?
|
| Syndrome | 1 | 2012 | 180 | 0.090 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 142 | 0.090 |
Why?
|
| Necrosis | 1 | 2012 | 148 | 0.090 |
Why?
|
| Bronchoscopy | 1 | 2012 | 88 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2012 | 208 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2012 | 117 | 0.090 |
Why?
|
| Infant | 1 | 2016 | 1693 | 0.080 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 253 | 0.080 |
Why?
|
| Age Factors | 1 | 2014 | 1585 | 0.080 |
Why?
|
| Risk Factors | 2 | 2012 | 5429 | 0.080 |
Why?
|
| Condylomata Acuminata | 1 | 2009 | 9 | 0.070 |
Why?
|
| United States | 2 | 2013 | 8093 | 0.070 |
Why?
|
| Ampicillin | 1 | 2008 | 12 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2008 | 15 | 0.070 |
Why?
|
| Food Microbiology | 1 | 2008 | 43 | 0.070 |
Why?
|
| Nevirapine | 1 | 2008 | 8 | 0.070 |
Why?
|
| Vancomycin | 1 | 2008 | 39 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 92 | 0.070 |
Why?
|
| Papillomavirus Vaccines | 1 | 2009 | 69 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 118 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2008 | 206 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 151 | 0.070 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2007 | 94 | 0.070 |
Why?
|
| Viral Load | 1 | 2008 | 230 | 0.060 |
Why?
|
| Pandemics | 1 | 2012 | 675 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 2483 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 138 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 102 | 0.030 |
Why?
|
| Oxygen | 1 | 2019 | 319 | 0.030 |
Why?
|
| Pericardiectomy | 1 | 2013 | 1 | 0.030 |
Why?
|
| Pericardiocentesis | 1 | 2013 | 4 | 0.030 |
Why?
|
| Cardiac Tamponade | 1 | 2013 | 14 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 175 | 0.020 |
Why?
|
| Chest Pain | 1 | 2013 | 85 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2013 | 246 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1219 | 0.020 |
Why?
|